Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

PPM1D mutations in circulating white blood cells and the risk for ovarian cancer.

Journal of the National Cancer Institute - 1 Jan 2014

Akbari Mohammad R, Lepage Pierre, Rosen Barry, McLaughlin John, Risch Harvey, Minden Mark, Narod Steven A

Abstract excerpt

We compared the frequency of PPM1D mutation in the white blood cells from 1295 ovarian cancer case patients and 834 control subjects. We found a truncating mutation in 20 case patients vs 1 control subject (odds ratio [OR] = 13.07; 95% confidence interval [CI] = 1.75 to 97.55; P < .001). The 12-y...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein
Share to Canada

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leukocytes

Share to Ovarian Neoplasms

Share to Phosphoprotein Phosphatases

Share to Proportional Hazards Models

Share to Protein Phosphatase 2C

Source

Identifiers

PMID: 24262437
DOI: 10.1093/jnci/djt323

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24262437-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

PPM1D mutations in circulating white blood cells and the risk for ovarian cancer.PMID 24262437Read ↗

PPM1D Mosaic Truncating Variants in Ovarian Cancer Cases May Be Treatment-Related Somatic Mutations.Semantic proximity Read ↗

Somatic Mosaic Mutations in PPM1D and TP53 in the Blood of Women With Ovarian Carcinoma.Semantic proximity Read ↗

Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer.Semantic proximity Read ↗

PPM1D in Solid and Hematologic Malignancies: Friend and Foe?Semantic proximity Read ↗

Truncating mutations of PPM1D are found in blood DNA samples of lung cancer patientsSemantic proximity Read ↗

Truncating and missense PPM1D mutations in early-onset and/or familial/hereditary prostate cancer patients.Semantic proximity Read ↗

Spectrum, prevalence, and clinical correlates of PPM1D mutations in patients with clonal hematopoiesis and clonal cytopenias.Semantic proximity Read ↗

The role of PPM1D in cancer and advances in studies of its inhibitorsSemantic proximity Read ↗

Protein phosphatase, Mg2+/Mn2+-dependent 1D (PPM1D) mutations in haematological cancer.Semantic proximity Read ↗

Cancer risk in DM1 is sex-related and linked to miRNA-200/141 downregulation.Semantic proximity Read ↗

PPM1D-truncating mutations confer resistance to chemotherapy and sensitivity to PPM1D inhibition in hematopoietic cellsSemantic proximity Read ↗

Genetic variants and mutations of PPM1D control the response to DNA damage.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.